Since there are no clinical studies with a good level of evidence, this evaluation is based mainly on the expertise of the multidisciplinary working group.
Limited-period use and the targeting of precisely defined clinical situations were accepted for certain chronic wounds (use as second-line therapy) or acute wounds (possible use as first-line therapy). In addition, precise conditions of use were defined.
|